-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

711. Cell Collection and Processing: Poster II

Cell Collection and Processing Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Satyajit Kosuri, MD1, Boglarka Gyurkocza, MD1, Sean Devlin, PhD2*, Molly Maloy, MS1*, Cristi Ciolino, MPH CCRP1*, Taylor Borrill, BA1*, Ann A. Jakubowski, MD, PhD1*, Esperanza B Papadopoulos, MD1, H.R. Castro-Malaspina, MD1, Guenther Koehne, MD, PhD1, Miguel-Angel Perales, MD1 and Sergio Giralt, MD1

1Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY

Robert Sheppard Nickel, MD, MSc1, Ashley Dulson2*, Diana Worthington-White, MEd2*, Muna Qayed, MD, MSc3 and Kuang-Yueh Chiang, MD, PhD3*

1Divison of Hematology, Children's National Health System, Washington, DC
2Children's Healthcare of Atlanta, Atlanta, GA
3Emory University, Atlanta, GA

Saloomeh Mokhtari1, Pedro Baptista2*, Dipen Vyas, PhD3*, Charles Jordan Freeman4*, Emma Moran, PhD5*, Christopher D Porada, PhD4, Shay Soker, PhD4* and Graca Almeida-Porada, MD, PhD1

1Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC
2Aragon Health Sciences Institute, Zaragoza
3Wake Forest Institute for Regenerative Medicine, winston Salem, NC
4Wake Forest Institute for Regenerative Medicine, Winston Salem, NC
5wake Forest Institute for Regenerative Medicine, winston Salem, NC

Armin Ghobadi, MD1*, Mark A Fiala, BS, CCRP1*, Giridharan Ramsingh, M.D2, Feng Gao, PhD3*, Camille N. Abboud, MD4, Keith Stockerl-Goldstein, MD5, Geoffrey L. Uy, MD6, Peter Westervelt, MD, PhD4 and John F. DiPersio, MD, PhD1

1Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
2Hematology, University of Southern California, Los Angeles, CA
3Department of Biostatistics, Washington University School of Medicine, Saint Louis, MO
4Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
5Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
6Division of Oncology, Washington University School of Medicine, St. Louis, MO

Thomas Porturas, PhD*, Mary Sell, BS, MT(ASCP)*, Leah Irwin, RN, MSN, CRNP*, Una O'Doherty, MD, PhD* and Carlos Hipolito Villa, MD, PhD*

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA

Jeffrey A. Boyd, MBA1*, Bruce L. Levine, PhD2,3, Kathrin Jinivizian, BS1*, Margit A. Jeschke, PhD1*, Megan M. Suhoski Davis, PhD3,4*, Zhaohui Zheng, MS3,5*, Daniel Stark, PhD6*, Liza Loidolt, MS, MBA1*, Christopher H. Keir, MD, MS7 and Patricia A. Wood, MD, PhD7

1Cell & Gene Therapies Unit, Novartis Pharmaceuticals Corporation, Morris Plains, NJ
2Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
3Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
5Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
6Cell & Gene Therapies Unit, Novartis Pharma AG, Basel, Switzerland
7Cell & Gene Therapies Unit, Novartis Pharmaceuticals Corporation, East Hanover, NJ

Aditi Shastri, MD1, Ira Braunschweig, MD2, Stefan Klaus Barta, MD, MRCP, MS3, Noah Kornblum, MD4, Olga Derman5*, Ramakrishna Battini, MD2*, Amit Verma, MD6, Paul S. Frenette, MD7 and Murali Janakiram, MD4

1Department of Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
2Department of Oncology, Montefiore Medical Center, Bronx, NY
3Fox Chase Cancer Center, Philadelphia, PA
4Department of Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
5Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY
6Department of Medicine-Oncology, Albert Einstein College of Medicine, Bronx, NY
7Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY

Junglim Lee, MD1, Byung-Su Kim, MD2, Soon- Hi Jang, MD PHD2* and Tai-Gyu KIM, MD PHD3*

1Daegu Fatima Hospital Public Cord Blood Bank, Daegu, South Korea
2Daegu Fatima Hospital Public Cord Blood Bank, DAEGU, South Korea
3Catholic Hematopoietic Stem Cell Bank, SEOUL, South Korea

Sanjay De Mel, BSc, FRCPath, MRCP,1*, Yunxin Chen, MBBS, MRCP,2*, Adeline Lin, BSc1*, Eng Soo Yap, MBBS1*, Teck Guan Soh3*, Joanna Mah4*, Melissa G. Ooi1*, Sathish Kumar Gopalakrishnan2*, Lara Kristina Sioco Donato2*, Nurul Aidah Abdul Halim2*, Wee-Joo Chng, MB, ChB, PhD5 and lip Kun Tan6*

1Department of Haematology/Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
2Department of Haematology, Singapore General Hospital, Singapore, Singapore
3Department of Laboratory Medicine, National University Hospital,, Singapore, Singapore
4National University Hospital, Singapore, Singapore
5Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore, Singapore
6Department of Laboratory Medicine, National University Hospital, Singapore, Singapore

*signifies non-member of ASH